Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
491
-
Total 13F shares, excl. options
-
44.6M
-
Shares change
-
+466K
-
Total reported value, excl. options
-
$10B
-
Value change
-
-$12.8M
-
Put/Call ratio
-
0.78
-
Number of buys
-
256
-
Number of sells
-
-237
-
Price
-
$223.96
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2023
594 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2023.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 491 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.6M shares
of 44.8M outstanding shares and own 99.66% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.75M shares), VANGUARD GROUP INC (4.61M shares), WELLINGTON MANAGEMENT GROUP LLP (3.78M shares), Avoro Capital Advisors LLC (2.87M shares), FMR LLC (2.54M shares), RENAISSANCE TECHNOLOGIES LLC (2.23M shares), STATE STREET CORP (1.8M shares), JANUS HENDERSON GROUP PLC (976K shares), GEODE CAPITAL MANAGEMENT, LLC (759K shares), and Assenagon Asset Management S.A. (666K shares).
This table shows the top 491 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.